Glaxosmithkline Pharmaceuticals Ltd Peer Comparison

Glaxosmithkline Pharmaceuticals Ltd Share Price
Detail Overview
Pharmaceuticals - MultinationalNSE
₹2,404.70
-29.00(-1.19%)
As on 23 Oct 2026 at 15:57
As of 23 Oct 2026 at 15:57, Glaxosmithkline Pharmaceuticals Ltd is trading at ₹2,404.70. The 52-week range stands at ₹2,088.10–₹3,120.70, with a market cap of ₹40.74 thousand crore. At a P/E of 38.49 and a dividend yield of 2.37%, it is a large-cap stock in the Pharmaceuticals sector.

Glaxosmithkline Pharmaceuticals Ltd Peer Comparison

StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,743.00
-15.00(-0.85%)
4,18,204.11,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,482.00
-133.30(-2.89%)
1,70,480.93,532.6 - 5,250.0
Cipla Ltd
₹1,337.00
6.10(+0.46%)
1,08,012.31,165.7 - 1,673.0
Dr Reddys Laboratories Ltd
₹1,224.50
-14.50(-1.17%)
1,02,206.61,101.0 - 1,414.9
Lupin Ltd
₹1,925.00
3.00(+0.16%)
88,028.31,892.9 - 2,529.5

Frequently asked questions

The market capitalisation of Glaxosmithkline Pharmaceuticals Ltd is approximately ₹40,739 crore, compared with ₹4,18,204 crore for its selected peer.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now